LXEH vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

LXEH

45.0
AI Score
VS
UTI Wins

UTI

49.0
AI Score

Investment Advisor Scores

LXEH

45score
Recommendation
HOLD

UTI

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LXEH UTI Winner
Forward P/E 0 27.248 Tie
PEG Ratio 0 1.8142 Tie
Revenue Growth -0.8% 7.2% UTI
Earnings Growth -22.5% -78.9% LXEH
Tradestie Score 45.0/100 49.0/100 UTI
Profit Margin 0.0% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LXEH 1M: +1.4% · 3M: +10.6% UTI 1M: -7.4% · 3M: -61.2%

Current Technical Phase

LXEH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $1.57

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.9%), weak momentum, RSI 35

RSI (14): 34.9 · Price: $19.38

Fundamentals Snapshot

Metric LXEH UTI
Market Cap — —
Forward P/E 0.0 26.4
Trailing P/E — 30.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin -0.1% 0.6%
Operating Margin -0.7% 0.0%
EPS -8.90 0.62
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.